Clinical Trials Unit, St. Luke's Hospital, Rathgar, Dublin, Ireland.
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):608-13. doi: 10.1016/j.ijrobp.2010.07.1994. Epub 2010 Oct 8.
To evaluate the predictive value of equivalent uniform doses (EUD) for late bladder and rectal toxicity after high-dose three-dimensional conformal radiation therapy (3D-CRT) to the prostate.
Using the method developed by Kutcher et al., EUDs for whole bladder and rectum were calculated from the dose-volume histograms of 180 patients with localized prostate cancer treated to 70-74 Gy with 3D-CRT. Late complications were recorded using the Radiation Therapy Oncology Group scale, correlated against EUD and known physical predictive indicators.
EUD is an independent prognostic factor for Grade 2+ long-term rectal and bladder toxicity after radiation treatment to the prostate. Patients receiving an EUD >63.1 Gy to the rectum have a statistically significant (10% vs. 30%; p = 0.002) higher risk of developing Grade 2+ late complications. Patients receiving an EUD >53.4 Gy to the bladder have a statistically significant (10% vs. 33%; p = 0.001) higher risk of developing Grade 2+ late complications.
It has been demonstrated that EUD is a strong independent predictive factor for Grade 2+ late complications after 3D-CRT to the prostate. Threshold values have been demonstrated for both bladder and rectum, above which there is a clinically significant increased risk of complications.
评估等剂量线(EUD)对高剂量三维适形放疗(3D-CRT)治疗前列腺后晚期膀胱和直肠毒性的预测价值。
使用 Kutcher 等人开发的方法,从 180 例接受 70-74 Gy 3D-CRT 治疗的局限性前列腺癌患者的剂量-体积直方图中计算出整个膀胱和直肠的 EUD。使用放射治疗肿瘤学组(RTOG)量表记录晚期并发症,并与 EUD 和已知的物理预测指标相关联。
EUD 是前列腺放射治疗后长期直肠和膀胱 2 级以上毒性的独立预后因素。直肠接受 EUD >63.1 Gy 的患者发生 2 级以上晚期并发症的风险具有统计学意义(10%比 30%;p = 0.002)。膀胱接受 EUD >53.4 Gy 的患者发生 2 级以上晚期并发症的风险具有统计学意义(10%比 33%;p = 0.001)。
已经证明,EUD 是 3D-CRT 治疗前列腺后 2 级以上晚期并发症的强有力独立预测因素。已经证明膀胱和直肠均存在阈值,超过该阈值,并发症的风险会显著增加。